Development of standard clinical endpoints for use in dengue interventional trials
Dengue is a major public health problem worldwide. Although several drug candidates have been evaluated in randomized controlled trials, none has been effective and at present, early recognition of severe dengue and timely supportive care are used to reduce mortality. While the first dengue vaccine...
Autori principali: | Tomashek, K, Wills, B, See Lum, L, Thomas, L, Durbin, A, Leo, Y, De Bosch, N, Rojas, E, Hendrickx, K, Erpicum, M, Agulto, L, Jaenisch, T, Tissera, H, Suntarattiwong, P, Collers, B, Wallace, D, Schmidt, A, Precioso, A, Narvaez, F, Thomas, S, Edelman, R, Siqueira, J, Cassetti, M, Dempsey, W, Gubler, D |
---|---|
Natura: | Journal article |
Lingua: | English |
Pubblicazione: |
Public Library of Science
2018
|
Documenti analoghi
Documenti analoghi
-
Development of standard clinical endpoints for use in dengue interventional trials
di: Tomashek, Kay M., et al.
Pubblicazione: (2018) -
Severe dengue categories as research endpoints—results from a prospective observational study in hospitalised dengue patients
di: Rosenberger, KD, et al.
Pubblicazione: (2020) -
Dogma in classifying dengue disease.
di: Farrar, J, et al.
Pubblicazione: (2013) -
Dogma in classifying dengue disease
di: Farrar, J, et al.
Pubblicazione: (2013) -
Helicopter EMS: Research Endpoints and Potential Benefits
di: Stephen H. Thomas, et al.
Pubblicazione: (2012-01-01)